Biogen Inc (BIIB)

300.50 -0.96  -0.32% NASDAQ May 28, 20:00 Delayed 2m USD

Biogen Cash from Operations (TTM):

7.086B for March 31, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Operations (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Operations (TTM) Data

View and export this data going back to 1984. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2020 7.086B
Dec. 31, 2019 7.079B
Sept. 30, 2019 7.014B
June 30, 2019 7.055B
March 31, 2019 6.190B
Dec. 31, 2018 6.188B
Sept. 30, 2018 5.811B
June 30, 2018 5.703B
March 31, 2018 5.773B
Dec. 31, 2017 4.551B
Sept. 30, 2017 4.615B
June 30, 2017 3.978B
March 31, 2017 3.807B
Dec. 31, 2016 4.587B
Sept. 30, 2016 4.249B
June 30, 2016 4.153B
March 31, 2016 4.202B
Dec. 31, 2015 3.919B
Sept. 30, 2015 3.609B
June 30, 2015 3.627B
March 31, 2015 3.570B
Dec. 31, 2014 2.942B
Sept. 30, 2014 2.878B
June 30, 2014 2.636B
March 31, 2014 2.271B
   
Dec. 31, 2013 2.345B
Sept. 30, 2013 1.984B
June 30, 2013 1.854B
March 31, 2013 1.864B
Dec. 31, 2012 1.880B
Sept. 30, 2012 1.846B
June 30, 2012 1.875B
March 31, 2012 1.669B
Dec. 31, 2011 1.728B
Sept. 30, 2011 1.685B
June 30, 2011 1.543B
March 31, 2011 1.541B
Dec. 31, 2010 1.625B
Sept. 30, 2010 1.473B
June 30, 2010 1.311B
March 31, 2010 1.111B
Dec. 31, 2009 1.075B
Sept. 30, 2009 1.203B
June 30, 2009 1.449B
March 31, 2009 1.496B
Dec. 31, 2008 1.562B
Sept. 30, 2008 1.501B
June 30, 2008 1.199B
March 31, 2008 1.125B
Dec. 31, 2007 1.021B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Benchmarks

Benchmarks
Amgen Inc 9.439B
Gilead Sciences Inc 9.003B
Eli Lilly and Co 4.908B

Cash from Operations (TTM) Range, Past 5 Years

Minimum 3.609B Sep 2015
Maximum 7.086B Mar 2020
Average 5.160B
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.